Why is Hester Bios falling/rising?

As of 18-Sep, Hester Biosciences Ltd is experiencing a decline in its stock price, currently at Rs 2,039.00, which reflects a decrease of Rs 11.0 or 0.54%. The stock has underperformed its sector by 1.59% today and has been on a consecutive decline for the last two days, resulting in a total drop of 1.12% during this period. Over the past week, the stock has fallen by 3.41%, while it has shown a modest increase of 6.09% over the past month. Despite positive financial results, including a significant net profit growth of 145.1% and consistent positive results over the last five quarters, the stock's long-term growth prospects appear weak, with a low ability to service debt and a high Debt to EBITDA ratio of 3.49 times. Additionally, the stock's valuation is considered expensive, and domestic mutual funds hold no stake, indicating a lack of confidence in the stock's price.
In the broader market context, the Sensex has increased by 1.80% over the past week, contrasting sharply with Hester Bios' performance. While the benchmark has shown a positive return of 6.24% year-to-date, Hester Bios has declined by 14.78% in the same timeframe. This significant underperformance relative to the market may contribute to investor sentiment that is further driving the stock down. The overall market's positive movement juxtaposed with Hester's struggles highlights the challenges the company faces in gaining investor confidence amidst its financial metrics and market position.